DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Franchise/Therapy Area Strategy and Planning

We partner with biopharmaceutical and medtech clients to optimize R&D and acquisition strategy through analysis of unmet need, commercial potential, and risk across therapeutic areas. Our deep understanding of the nuances of relevant markets, products, and therapeutic areas helps to inform realistic, targeted and data-driven assumptions and recommendations.

Deep and broad therapeutic, clinical and commercial expertise

 

Data-driven Results

Whether a client seeks to expand share in a therapeutic area/market or is looking to identify/prioritize asset(s) to fit strategically within its portfolio, DRGC has long-standing experience to support value-building activities.  Ultimately, our goal is to help our clients develop a strategy that maximizes the franchise's synergies and coverage of different market segments, while minimizing undesired cannibalization.

 

Evaluation Factors

Depending on the project, we evaluate a range of factors, such as unmet needs, competitive environment, variable clinical/commercial opportunities across potential development options, macrotrends affecting the industry & therapeutic area (including market access, technological advances, broader political, economic and social patterns), development timelines/risk, pricing/market access dynamics--in order to provide data-driven recommendations with a view to the potential impact of market events and trends.

 

 

Capabilities include:

  • Future Market Landscape and Environmental Analysis
  • Environmental Landscape Analysis
  • Therapeutic Area & Franchise Strategy
  • Strategic & Tactical Plan Development